September 12, 2013—The Department of Health and Human Services Office of Inspector General (OIG) has urged the Centers for Medicare and Medicaid Services (CMS) to consider calling for the enactment of a Medicare Part B drug rebate program. … [Read more...]
Archives for September 2013
Onyx Pharmaceuticals Providing 340B Refunds on Kyprolis
Gives providers until end of this year to claim repayment for overchargesSeptember 9, 2013—Biopharmaceutical manufacturer Onyx, which is being purchased by biotech giant Amgen for $10.4 billion, has announced that 340B covered entities that bought its injectable oncology medication Kyprolis during the first quarter of 2013 might be eligible for refunds for overcharges. … [Read more...]
HRSA Releases Findings From 8 More 340B Provider Audits
42 down and 9 to go out of the 51 audits performed in 2012September 5, 2013—The Health Resources and Services Administration (HRSA) has released eight more brief summaries of findings from its audits of 340B covered entities in 2012, bringing the total to 42 out of 51 audits conducted last year. … [Read more...]
HRSA Publishes 340B Orphan Drug Exclusion List
Registry will govern sales covered by new regulation beginning Oct. 1September 4, 2013—The Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs (OPA) has published its first quarterly list of orphan drugs subject to exclusion from 340B pricing in certain circumstances. … [Read more...]
Drug Manufacturer Lilly Is Auditing 340B Hospitals
Focus is on perceived drug diversion to inpatients, executive saysSeptember 4, 2013—Eli Lilly & Co. is the second known drug manufacturer to obtain federal approval to conduct its own audits of 340B covered entities, it has emerged. … [Read more...]
The Many Ways 340B Is Making a Positive Difference
Setting the record straight about 340B involves more than just responding to the program's critics and pointing out where they’ve bent the truth or worse. Setting the record straight also means telling the story of how safety net hospitals and other caregivers use their 340B savings to meet the program's purpose of stretching scarce federal resources, serving more patients, and … [Read more...]